Epinephrine inhibits endotoxin-induced IL-1β production: roles of tumor necrosis factor-α and IL-10.

Epinephrine has been found to inhibit the production of the proinflammatory cytokine tumor necrosis factor (TNF)-α and to enhance the production of anti-inflammatory cytokine interleukin (IL)-10. To determine the effect of epinephrine on IL-1β production, the following experiments were performed: 1) blood obtained from subjects at 4-21 h after the start of a continuous infusion of epinephrine (30 ng ⋅ kg-1 ⋅ min-1) produced less IL-1β after ex vivo stimulation with lipopolysaccharide (LPS), compared with blood drawn from subjects infused with saline; 2) in whole blood in vitro, epinephrine caused a dose-dependent decrease in LPS-induced IL-1β production, which was likely mediated via adrenergic receptors; and 3) inhibition of TNF and enhancement of IL-10 both contributed to epinephrine-induced inhibition of IL-1β production. Epinephrine, either endogenously produced or administered as a component of sepsis treatment, may attenuate excessive activity of proinflammatory cytokines early in the course of systemic infection.

[1]  O. Lantz,et al.  Regulation of interleukin‐10 production by β‐adrenergic agonists , 1996, European journal of immunology.

[2]  T. van der Poll,et al.  Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[3]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[4]  T. van der Poll,et al.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.

[5]  L. Thomsen,et al.  IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer. , 1996, Journal of immunology.

[6]  S. Lowry,et al.  Biological Responses to Endotoxin in Humans1 , 1995 .

[7]  B. Champion,et al.  Anti‐inflammatory activity of salmeterol: down‐regulation of cytokine production , 1995, Clinical and experimental immunology.

[8]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[9]  G. Monastra,et al.  Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. , 1993, Immunology letters.

[10]  C. Hunter,et al.  Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. , 1992, Journal of immunology.

[11]  D. de Groote,et al.  Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. , 1992, Cytokine.

[12]  D. Remick,et al.  Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. , 1992, The Journal of clinical investigation.

[13]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[14]  J. Walters,et al.  Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes. , 1991, The Journal of clinical investigation.

[15]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[16]  T. J. Hayes,et al.  Comparison between effects of interleukin-1 alpha administration and sublethal endotoxemia in primates. , 1991, The American journal of physiology.

[17]  Robert C. Thompson,et al.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock , 1990, Nature.

[18]  O. Silvennoinen,et al.  Control of interleukin-1 beta expression by protein kinase C and cyclic adenosine monophosphate in myeloid leukemia cells. , 1990, Blood.

[19]  Y. Ohmori,et al.  cAMP differentially regulates expression of mRNA encoding IL-1 alpha and IL-1 beta in murine peritoneal macrophages. , 1990, Journal of immunology.

[20]  M. Gougerot-Pocidalo,et al.  Differential regulation of IL 6, IL 1 A, IL 1β and TNFα production in LPS-stimulated human monocytes: Role of cyclic AMP , 1990 .

[21]  M. Hurme.  Modulation ofinterleukin‐1β production by cyclic AMP in human monocytes , 1990 .

[22]  K. Tracey,et al.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia , 1989, The Journal of experimental medicine.

[23]  I. Otterness,et al.  Regulation of Monokine Gene Expression: Prostaglandin E2 Suppresses Tumor Necrosis Factor but Not Interleukin‐1α or β‐mRNA and Cell‐Associated Bioactivity , 1989 .

[24]  C. Tannenbaum,et al.  Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. , 1989, Journal of immunology.

[25]  E. Girardin,et al.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. , 1988, The New England journal of medicine.

[26]  S. Haskill,et al.  Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. , 1988, Journal of immunology.

[27]  J. Kenney,et al.  Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity. , 1987, Journal of immunology.

[28]  K N Frayn,et al.  HORMONAL CONTROL OF METABOLISM IN TRAUMA AND SEPSIS , 1986, Clinical endocrinology.

[29]  R. Snyderman,et al.  Hormonal activation of adenylate cyclase in macrophage membranes is regulated by guanine nucleotides. , 1983, Journal of immunology.

[30]  M. Cassatella.  The production of cytokines by polymorphonuclear neutrophils. , 1995, Immunology today.

[31]  S. Ben-Efraim,et al.  Prostaglandin E2 inhibits the release of tumor necrosis factor-α, rather than interleukin 1β, from human macrophages , 1992 .